Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02136004 · ClinicalTrials.gov registry record · NA

The Closer Trial: A Safety and Efficacy Study of the Rex Medical Vascular Sealing System

A NA study of Surgical Wound, sponsored by Rex Medical.

Completed
Registry status
NA
Development phase
220
Enrollment target
12
Study locations

NCT02136004 is a NA study of Surgical Wound that has completed, run by Rex Medical. The registered enrollment target is 220 participants, above the 82-participant average among 17 other Surgical Wound trials with a reported enrollment target (168% higher). The trial reports 12 study locations across 10 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02136004, a NA study of Surgical Wound, has completed, sponsored by Rex Medical.

COMPLETED
Registry status
NA
Development phase
220 participants
Enrollment target
12
Study locations

Study Summary

The objective of this trial is to demonstrate the safety and effectiveness of the Rex Medical Closer Vascular Sealing System in sealing femoral arterial access sites.

Conditions Studied

Interventions

  • DEVICE Closer VSS

Study Locations (12)

Pennsylvania

  • Geisinger Health Center - Danville
  • Geisinger Health Center - Wilkes-Barre
  • Pinnacle Health - Wormleysburg

California

  • UC Davis Medical Center - Sacramento

Colorado

  • Colorado Neurological Institute - Englewood

District of Columbia

  • Washington Hospital Center - Washington D.C.

Louisiana

  • Lafayette General Medical Center/Cardiovascular Institute of the South - Lafayette

New York

  • New York Presbyterian Hospital - New York

Ohio

  • North Ohio Research - Elyria

Oklahoma

  • Oklahoma Heart Institute - Tulsa

Trial Details

FieldValue
Enrollment Target 220 participants
Start Date 2014-05
Est. Completion 2015-02
Phase NA

Sponsor

Rex Medical

3 total trials

What the Registry Record Tells You About NCT02136004

The ClinicalTrials.gov registry entry for NCT02136004 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 220 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 82-participant average among 17 other Surgical Wound trials with a reported enrollment target (168% higher). The listed sponsor is Rex Medical, which has 3 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Surgical Wound appearing as the primary indexed condition, and to 1 intervention - of which Closer VSS is the first listed.

NCT02136004 reports 12 study locations spanning 10 distinct geographic areas - top geographies include Pennsylvania, California, Colorado.

Frequently Asked Questions

What is clinical trial NCT02136004 about?

NCT02136004 is a clinical study titled "The Closer Trial: A Safety and Efficacy Study of the Rex Medical Vascular Sealing System". The objective of this trial is to demonstrate the safety and effectiveness of the Rex Medical Closer Vascular Sealing System in sealing femoral arterial access sites.

What is the current status of trial NCT02136004?

This trial is currently completed. It is a NA study. The enrollment target is 220 participants. The study started on 2014-05. Estimated completion is 2015-02.

What conditions does trial NCT02136004 study?

This clinical trial studies the following conditions: Surgical Wound.

What interventions are being tested in trial NCT02136004?

The interventions under investigation include: Closer VSS (DEVICE).

Who is sponsoring clinical trial NCT02136004?

This trial is sponsored by Rex Medical, which has 3 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02136004 being conducted?

This trial has 12 study locations across California, Colorado, District of Columbia, Louisiana, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Surgical Wound

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.